Patents by Inventor Vijay Gupte

Vijay Gupte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT AND COMPOSITIONS WITH XANTHINE OXIDASE INHIBITORS
    Publication number: 20180311217
    Abstract: Methods and pharmaceutical compositions for reducing number of gout flares experienced by a patient are disclosed. The methods can comprise administering to a patient with hyperuricemia an effective amount of a xanthine oxidase inhibitor in a modified release dosage form once daily or in an immediate release dosage form two or more times daily to prevent at least one gout flare or reduce the number of gout flares experienced by the patient.
    Type: Application
    Filed: December 1, 2017
    Publication date: November 1, 2018
    Applicants: Takeda Pharmaceuticals U.S.A., Inc., Teijin Pharma Limied
    Inventors: Lhanoo Gunawardhana, Vijay Gupte, Himanshu Naik, Michael Mayer, Kanji Komatsu
  • Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
    Patent number: 9937157
    Abstract: The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: April 10, 2018
    Assignee: Takeda Pharmaceuticals U.S.A., Inc.
    Inventors: Rajneesh Taneja, Vijay Gupte, Majid Vakilynejad
  • NOVEL MODIFIED RELEASE DOSAGE FORMS OF XANTHINE OXIDOREDUCTASE INHIBITOR OR XANTHINE OXIDASE INHIBITORS
    Publication number: 20160317505
    Abstract: The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.
    Type: Application
    Filed: January 29, 2016
    Publication date: November 3, 2016
    Applicant: Takeda Pharmaceuticals U.S.A., Inc.
    Inventors: Rajneesh Taneja, Vijay Gupte, Majid Vakilynejad
  • Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
    Patent number: 9248119
    Abstract: The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: February 2, 2016
    Assignee: Takeda Pharmaceuticals U.S.A., Inc.
    Inventors: Rajneesh Taneja, Vijay Gupte, Majid Vakilynejad
  • METHODS OF TREATMENT AND COMPOSITIONS WITH XANTHINE OXIDASE INHIBITORS
    Publication number: 20140357683
    Abstract: Methods and pharmaceutical compositions for reducing number of gout flares experienced by a patient are disclosed. The methods can comprise administering to a patient with hyperuricemia an effective amount of a xanthine oxidase inhibitor in a modified release dosage form once daily or in an immediate release dosage form two or more times daily to prevent at least one gout flare or reduce the number of gout flares experienced by the patient.
    Type: Application
    Filed: May 30, 2014
    Publication date: December 4, 2014
    Inventors: Lhanoo Gunawardhana, Vijay Gupte, Himanshu Naik, Michael Mayer, Kanji Komatsu
  • NOVEL MODIFIED RELEASE DOSAGE FORMS OF XANTHINE OXIDOREDUCTASE INHIBITOR OR XANTHINE OXIDASE INHIBITORS
    Publication number: 20110311620
    Abstract: The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.
    Type: Application
    Filed: June 15, 2011
    Publication date: December 22, 2011
    Applicant: Takeda Pharmaceuticals North America, Inc.
    Inventors: Rajneesh Taneja, Vijay Gupte, Majid Vakilynejad
  • Pharmaceutical compositions of ilaparazole
    Publication number: 20080050444
    Abstract: The present invention relates to pharmaceutical compositions comprising solid particles of an active ingredient that have a particle size of from about 0.1 micron to about 100 microns.
    Type: Application
    Filed: December 15, 2006
    Publication date: February 28, 2008
    Inventors: Rajneesh Taneja, Steve Berge, Vijay Gupte